Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Five Oxford Clinical Medical Students place in top 10% in prestigious national Ophthalmology Duke Elder Prize Examination

Image courtesy of Shutterstock

Fifth year Clinical Medical student, Mr John Logan (St Edmund Hall), gained an impressive 14th place in the Royal College of Ophthalmology's annual Prize Examination. Mr Logan was one of 370 medical students from 38 medical schools across the UK and Ireland who took the exam this year. In addition, Mr Benjamin Ng (5th Year/Christ Church College) and Mr Alexander Noar (6th Year/St John’s College), were both ranked 17th and Miss Anni Ding (6th Year/St John’s College) and Mr Dun Jack Fu (Graduate Entry 4th Year/St Hugh’s College) were placed in the top 10%.

The Royal College of Ophthalmology advise that the standard of the exam is deliberately high and those students taking the top places are to be congratulated. The names of students gaining a top 20 place are published and the candidate gaining the highest mark is offered the chance to visit St John’s Eye Hospital in Jerusalem or a monetary prize of £400. 

Questions are mostly based on clinical ophthalmology but other areas covered include ocular physiology, anatomy and pathology as well as genetics of eye conditions and socio-economic medicine relevant to ophthalmology  (for example, blind registration or world blindness).  In the clinical questions all the sub-speciality areas within ophthalmology are covered.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.